<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35587200</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1098-5522</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>19</Day>
            </PubDate>
          </JournalIssue>
          <Title>Infection and immunity</Title>
          <ISOAbbreviation>Infect Immun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Macrophage Cell Lines and Murine Infection by Salmonella enterica Serovar Typhi L-Form Bacteria.</ArticleTitle>
        <Pagination>
          <StartPage>e0011922</StartPage>
          <MedlinePgn>e0011922</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/iai.00119-22</ELocationID>
        <Abstract>
          <AbstractText>Antibiotic resistance of pathogenic bacteria has emerged as a major threat to public health worldwide. While stable resistance due to the acquisition of genomic mutations or plasmids carrying antibiotic resistance genes is well established, much less is known about the temporary and reversible resistance induced by antibiotic treatment, such as that due to treatment with bacterial cell wall-inhibiting antibiotics such as ampicillin. Typically, ampicillin concentration in the blood and other tissues gradually increases over time after initiation of the treatment. As a result, the bacterial population is exposed to a concentration gradient of ampicillin during the treatment of infectious diseases. This is different from <i>in vitro</i> drug testing, where the organism is exposed to fixed drug concentrations from the beginning until the end. To mimic the mode of antibiotic exposure of microorganisms within host tissues, we cultured the wild-type, ampicillin-sensitive Salmonella enterica serovar Typhi Ty2 strain (<i>S.</i> Typhi Ty2) in the presence of increasing concentrations of ampicillin over a period of 14â€‰days. This resulted in the development of a strain that displayed several features of the so-called L-form of bacteria, including the absence of the cell wall, altered shape, and lower growth rate compared with the parental form. Studies of the pathogenesis of <i>S</i>. Typhi L-form showed efficient infection of the murine and human macrophage cell lines. More importantly, <i>S</i>. Typhi L-form was also able to establish infection in a mouse model to the extent comparable to its parental form. These results suggested that L-form generation following the initiation of treatment with antibiotics could lead to drug escape of <i>S</i>. Typhi and cell to cell (macrophages) spread of the bacteria, which sustain the infection. Oral infection by the L-form bacteria underscores the potential of rapid disease transmission through the fecal-oral route, highlighting the need for new approaches to decrease the reservoir of infection.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Ganguli</LastName>
            <ForeName>Debayan</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Chakraborty</LastName>
            <ForeName>Swarnali</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chakraborty</LastName>
            <ForeName>Suparna</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pal</LastName>
            <ForeName>Ananda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gope</LastName>
            <ForeName>Animesh</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Das</LastName>
            <ForeName>Santasabuj</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-0745-469X</Identifier>
            <AffiliationInfo>
              <Affiliation>ICMR-National Institute of Cholera and Enteric diseases, Beleghata, Kolkata, West Bengal, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Infect Immun</MedlineTA>
        <NlmUniqueID>0246127</NlmUniqueID>
        <ISSNLinking>0019-9567</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">L-form</Keyword>
        <Keyword MajorTopicYN="N">Salmonella</Keyword>
        <Keyword MajorTopicYN="N">ampicillin</Keyword>
        <Keyword MajorTopicYN="N">antibiotic resistance</Keyword>
        <Keyword MajorTopicYN="N">macrophage</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>9</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35587200</ArticleId>
        <ArticleId IdType="doi">10.1128/iai.00119-22</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
